DexCom earnings beat by $0.03, revenue topped estimates
Investing.com - Lands’ End (NASDAQ: LE) reported fourth quarter EPS of $0.57, $0.02 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $441.7M versus the consensus estimate of $464.1M.
Guidance
Lands’ End sees Q1 2026 EPS of $-0.22-$-0.13
Lands’ End sees FY 2026 EPS of $0.48-$0.86 versus the analyst consensus of $0.45.
Lands’ End’s stock price closed at $11.44. It is down -12.47% in the last 3 months and up 42.29% in the last 12 months.
Lands’ End saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Lands’ End’s stock price’s past reactions to earnings here.
According to InvestingPro, Lands’ End’s Financial Health score is "fair performance".
Check out Lands’ End’s recent earnings performance, and Lands’ End’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar